
snack · meal-prep · 40 min
Pumpkin oat muffins
Soft pumpkin and oat muffins with yogurt in the batter, lightly sweetened and easy to portion.
By GLP-3 Wiki · Updated September 2026 · How we review
AI-generated recipe illustration
makes 6 servings
One serving: 2 muffins. Nutrition is estimated per serving; changing the batch size scales the ingredients.
Prep: 10 min · Cook: 25 min · Rest / chill: 5 min · Total: 40 min
Contains: egg, milk. Check ingredient labels for allergens and cross-contact.
Ingredients
- 120 gRolled oats — blend to flour
- 180 gCanned pumpkin puree
- 300 gPlain nonfat Greek yogurt
- 2Large egg
- 60 ml1% milk
- 30 gMaple syrup
- 4 gBaking powder
- 2 gGround cinnamon
- 5 gOlive oil — for the tin
Steps
Prepare
Heat the oven to 350°F / 180°C and lightly oil 12 standard muffin wells. Blend the oats into a fine flour.
Mix the batter
Whisk pumpkin, yogurt, eggs, milk and maple syrup until smooth. Fold in oat flour, baking powder and cinnamon just until combined.
Bake
Divide evenly between the wells, keeping them no more than three-quarters full, and bake for 22–25 minutes, until the tops spring back, centers reach 160°F / 71°C and a skewer comes out without wet batter.
Cool and portion
Rest in the tin for 5 minutes, then transfer to a rack. Two muffins make one base serving; a single muffin is a smaller snack.
For a smaller portion
Have one muffin first and save the second. These are moist oat muffins, so warm gently if you prefer a softer crumb.
Notes
- Refrigerate in shallow containers within 2 hours, or 1 hour above 90°F / 32°C. Keep at 40°F / 4°C or below for up to 3 days; reheat the portion you need to 165°F / 74°C.
- Use plain pumpkin puree, not sweetened pumpkin pie filling. Freeze cooled muffins for up to 2 months.
Download the 50-recipe book (PDF)
Prints ingredients for 6 servings, with nutrition per serving.
Related guides
- What this is
- Educational information, not medical advice. It reports published research — it doesn’t recommend that you use, obtain, or supply anything.
- Regulatory status
- Retatrutide and similar peptides are investigational — not approved by the FDA or any regulator. Semaglutide and tirzepatide are prescription-only medicines, available only through a licensed prescriber.
- Our standard
- Every claim traces to a primary source. We label the strength of evidence and flag estimates as estimates — never as clinical fact.
- No commercial ties
- We don’t sell, supply, or link to suppliers of any medicine, and aren’t affiliated with any manufacturer.
Do not make decisions about your health without consulting a qualified healthcare provider. For trial enrolment, see ClinicalTrials.gov. More on how we review.